Firdapse is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Catalyst Pharmaceuticals, Inc.. The primary component is Amifampridine Phosphate.
Product ID | 69616-211_0cecc1e6-ebdf-480a-be77-f2ef0fcbc897 |
NDC | 69616-211 |
Product Type | Human Prescription Drug |
Proprietary Name | Firdapse |
Generic Name | Amifampridine Phosphate |
Dosage Form | Tablet |
Route of Administration | ORAL |
Marketing Start Date | 2019-01-07 |
Marketing Category | NDA / NDA |
Application Number | NDA208078 |
Labeler Name | Catalyst Pharmaceuticals, Inc. |
Substance Name | AMIFAMPRIDINE PHOSPHATE |
Active Ingredient Strength | 10 mg/1 |
Pharm Classes | Potassium Channel Blocker [EPC],Potassium Channel Antagonists [MoA] |
NDC Exclude Flag | N |
Listing Certified Through | 2022-12-31 |
Marketing Start Date | 2019-01-07 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA208078 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2019-01-07 |
Marketing Category | NDA |
Application Number | NDA208078 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-01-07 |
Marketing Category | NDA |
Application Number | NDA208078 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2019-01-07 |
Marketing Category | NDA |
Application Number | NDA208078 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2019-01-07 |
Ingredient | Strength |
---|---|
AMIFAMPRIDINE PHOSPHATE | 10 mg/1 |
SPL SET ID: | f015fe60-3128-4a43-8c31-19fc6b5def3f |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
FIRDAPSE 86082826 4700764 Live/Registered |
BioMarin Huxley Ltd. 2013-10-04 |
FIRDAPSE 77904586 not registered Dead/Abandoned |
Huxley Pharmaceuticals, Inc. 2010-01-04 |
FIRDAPSE 77830438 not registered Dead/Abandoned |
Huxley Pharmaceuticals, Inc. 2009-09-19 |